With expected sales for GLP1Rs in obesity estimated to surpass $126 billion by 2030, this drug category presents a lucrative ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
A new Biden administration proposal could allow millions of Americans with obesity to access weight-loss drugs like Wegovy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback